MENU
GERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Geron (GERN) Earnings Date & Reports
Geron Corp is a biopharmaceutical company focused on blood cancers... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
GERN is expected to report earnings to fall 60.00% to 0 cents per share on November 11
Q3'26
Est.
$-0.01
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.02
Q3'25
Est.
$-0.03
The last earnings report on August 05 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 2.67M shares outstanding, the current market capitalization sits at 976.56M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutic products for cancer
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
258
Web
https://www.geron.com